C

Cansortium Inc
CNSX:TIUM.U

Watchlist Manager
Cansortium Inc
CNSX:TIUM.U
Watchlist
Price: 0.055 CAD
Market Cap: 33.5m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+61%
Revenue
Forecast
+6%
Operating Income
Forecast
+56%
Net Income
Forecast
+61%

Wall Street
Price Targets

TIUM.U Price Targets Summary
Cansortium Inc

There are no price targets for TIUM.U.
TIUM.U Lowest Forecast
Wall Street Target
Not Available
TIUM.U Average Forecast
Wall Street Target
Not Available
TIUM.U Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cansortium Inc Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
2% Downside
FUM
Futura Medical PLC
225% Upside
4530
Hisamitsu Pharmaceutical Co Inc
3% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
15% Upside
SUPN
Supernus Pharmaceuticals Inc
2% Downside
FUM
Futura Medical PLC
225% Upside
4530
Hisamitsu Pharmaceutical Co Inc
3% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
15% Upside
IPN
Ipsen SA
11% Upside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
36% Downside

Revenue
Forecast

Revenue Estimate
Cansortium Inc

For the last 4 years the compound annual growth rate for Cansortium Inc's revenue is 36%. The projected CAGR for the next 1 year is 34%.

36%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Cansortium Inc

The compound annual growth rate of Cansortium Inc's operating income for the next 1 year is 41%.

N/A
Past Growth
41%
Estimated Growth
Estimates Accuracy
15%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Cansortium Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
What are analyst estimates?

See Also

Summary
TIUM.U intrinsic value, competitors valuation, and company profile.
DCF Valuation
TIUM.U stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TIUM.U stock valuation using valuation multiples.
Wall Street Estimates
TIUM.U price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TIUM.U stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TIUM.U's stock price target?
Not Available

TIUM.U doesn't have any price targets made by Wall Street professionals.

What is Cansortium Inc's Revenue forecast?
Projected CAGR
34%

For the last 4 years the compound annual growth rate for Cansortium Inc's revenue is 36%. The projected CAGR for the next 1 year is 34%.

What is Cansortium Inc's Operating Income forecast?
Projected CAGR
41%

The compound annual growth rate of Cansortium Inc's operating income for the next 1 year is 41%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 277,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.